UK NEQAS Position Statement Regarding Temporary Pause in QAPC/NQAAP Activity
November 3, 2025Response to the pause in activity of the QAPC and NQAAPs UK NEQAS regrets the pause in activity of the QAPC and NQAAP oversight of laboratory performance from January 1st, 2026, as notified by the RCPath, IBMS and LabMed. UK NEQAS supports the need for an independent system of review of both laboratory and method-related […]
REACH
July 26, 2024Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) REACH is the EU regulation governing the manufacture and import of chemical substances into the European Union. In the UK, this is covered by the UK REACH regulation that applies to the majority of chemical substances that are manufactured in or imported into Great Britain (GB) (England, […]
Pathology in Practice
May 29, 2024UK NEQAS Feature in May Edition of Pathology in Practice We’re proud to announce that we feature in the May edition of Pathology in Practice. This prominent appearance highlights the exceptional work UK NEQAS undertakes and is introduced with a striking blue front cover. Readers can find UK NEQAS throughout the publication on pages 3, […]
Published Guidelines
January 8, 2024UK NEQAS for Histocompatibility & Immunogenetics (H&I) and BSHI have published their guidelines on Laboratory testing and clinical interpretation of HLA genotyping results supporting the diagnosis of coeliac disease. Click here to read the published guidelines. Authors: Deborah Pritchard (UK NEQAS H&I, Velindre University NHS Trust, Cardiff) | Arthi Anand (H&I Laboratory, North west London Pathology, […]